AtriCure, Inc.
corporate_fare Company Profile
AtriCure, Inc. (NASDAQ:ATRC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 10 items for ATRC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-27, rated 7/10. Across its 10 most recent items scored 7 or higher, the top rating is 9/10, with 4 rated 8 or above. Recent SEC coverage for ATRC spans 10-Q, 8-K, 8-K/A, DEF 14A.
Recent high-impact activity:
- AtriCure Swings to Q2 Profit on 12.8% Revenue Growth; SentreHEART Lawsuit Seeks $260M
- AtriCure Swings to Profit in Q2, Raises Full-Year Profitability Outlook
- Shareholders Approve 2.25 Million New Shares for Equity Incentive and ESPP
- AtriCure Amends Q1 Report to Add Full-Year 2026 Profitability Guidance
- AtriCure Issues 2026 Revenue Guidance of $600M-$610M
Financial Snapshot
Short Interest & Short Volume
3.62 days to coverFINRA reported short interest of 4,279,518 shares in ATRC as of the September 15, 2026 settlement, a 3.3% increase from the prior period — about 3.6 days to cover at its recent average daily volume. On October 2, 2026, 59.3% of ATRC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.